Outbreak of life-threatening coagulopathy associated with synthetic cannabinoids use

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Distributed via the CDC Health Alert Network
  
  May 25, 2018, 1130 ET (11:30 AM ET)
  
  CDC HAN-00410
  
  The Centers for Disease Control and Prevention (CDC) is providing information on: 1) the current status of a multistate outbreak of coagulopathy from exposure to synthetic cannabinoid products containing a vitamin K-dependent antagonist agent, such as brodifacoum; 2) signs and symptoms of presenting patients from this outbreak and which patients are at risk; 3) laboratory testing options that are available to help identify and classify cases; 4) available resources that may help clinicians make decisions; and 5) to whom to report possible cases.
  
  
• Subjects:
  Blood Coagulation Disorders Cannabinoids Designer Drugs Rodenticides Substance Abuse
• Source:
  HAN ; 410
• Series:
  Health Alert Network
• Document Type:
  HAN Health Advisory
• Place as Subject:
  United States
• Pages in Document:
  3 unnumbered pages
• Issue:
  410
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:cea451dac7f072ceb6292956671f5be5782032795f9b29c34e190a10ef79ac7c614eb263ab7e4647fd0ab93588d7975d155a216313819ce1deac8f361bcf7cb4
• Download URL:
  https://stacks.cdc.gov/view/cdc/54361/cdc_54361_DS1.pdf
• File Type:
  [PDF - 67.73 KB ]